TB006 is an investigational drug that is available to eligible patients at Universal Neurological Care through the Expanded Access Program (EAP), a program authorized by the FDA. TB006 is experimental and still undergoing clinical testing, and it is not yet FDA approved.
If you enroll in and are accepted into a clinical trial, the medication is free. However, there is a chance of being randomized into the placebo group.
If you decide to obtain TB006 through the EAP, you should be aware that the medication is expensive. The price includes:
Please contact our office at (904) 404-7044 for pricing.
To learn about eligibility and how to get access, visit our TB006 page or call Universal Neurological Care at (904) 404-7044 to schedule a consultation with Dr. Asad.




